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The Transcription Factor NFAT4 Is Involved
in the Generation and Survival of T Cells
in the cytoplasm as phosphorylated forms. Upon activa-
tion, sustained increases in calcium activate the phos-
phatase calcineurin, which subsequently dephosphory-
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1992; Beals et al., 1997a). The dephosphorylated NFATHarvard School of Public Health
is quickly translocated into the nucleus where, in syn-²Department of Medicine
ergy with AP-1, Maf, and/or NIP45 proteins, it transacti-Harvard Medical School
vates a variety of cytokine and other activation genesBoston, Massachusetts 02115
including IL-2, IL-4, and GM-CSF (Cockerill et al., 1993;³Tularik, Inc.
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Dephosphorylated NFAT is then rephosphorylated on
serine residues by GSK3 and translocated back to the
cytoplasm (Beals et al., 1997b). Interestingly, it has re-
Summary cently been demonstrated that the JNK signal transduc-
tion pathway opposes the calcineurin-mediated nuclear
Nuclear factor of activated T cells (NFAT) is a family import of NFAT4 but not the other NFAT family members
of four related transcription factors implicated in cyto- (Chow et al., 1997). The activation-dependent dephos-
kine and early response gene expression in activated phorylation and translocation of NFAT can be blocked
lymphocytes. Here we report that NFAT4, in contrast by immunosuppressive drugs such as cyclosporin A
to NFATp and NFATc, is preferentially expressed in (CsA) or tacrolimus (FK506), which efficiently inhibit cal-
DP thymocytes. Mice lacking NFAT4 have impaired cineurin (Emmel et al., 1989).
development of CD4 and CD8 SP thymocytes and pe- In vitro experiments using electrophoretic mobility
ripheral T cells as well as hyperactivation of peripheral shift assays and transient transfection have demon-
T cells. The thymic defect is characterized by in- strated that all NFAT members can bind to and transacti-
creased apoptosis of DP thymocytes. The increased vate the same set of NFAT sites derived from the IL-2 and
apoptosis and hyperactivation may reflect heightened IL-4 promoters, although NFATp and NFATc account for
sensitivity to TcR-mediated signaling. Further, mice the majority of the binding activity (Rao et al., 1997;
lacking NFAT4 have impaired production of Bcl-2 Timmerman et al., 1997). However, the distinct tissue
mRNA and protein. NFAT4 thus plays an important distribution and pattern of induction in response to ex-
role in the successful generation and survival of T ternal stimuli of each NFAT protein suggests that they
cells. subserve different functions. For example, as deter-
mined by Northern blot analysis, three of the four NFAT
members (NFATp, NFATc, and NFAT4) are expressedIntroduction
in lymphoid organs. Among them, NFATp and NFATc
are constitutively expressed at low levels, but onlyNuclear factor of activated T cells (NFAT) is a family of
NFATc is up-regulated upon stimulation through the Tproteins related to the NF-kB family. Initially identified
cell receptor. On the otherhand, NFAT4is predominantlyas a T cell±specific transcription factor that bound to the
expressed in thymus rather than peripheral lymphoidARRE site of the IL-2 promoter upon antigen stimulation,
organs, raising the possibility that it is involved in thymo-NFAT activity has now been demonstrated in a variety
cyte differentiation (Hoey et al., 1995; Masuda et al.,of cell types (Durand et al., 1988; Shaw et al., 1988;
1995). This hypothesis isconsistent with the observationCrabtree, 1989; Rao et al., 1997). Presently, the NFAT
that CsA is able to block the maturation of double-posi-family contains at least four members: NFATp (NFAT1
tive (DP) thymocytes to single-positive (SP) thymocytesor NFAT c2), NFATc (NFAT2or NFATc), NFAT3 (NFATc4),
both in vivo and in vitro (Jenkins et al., 1988; Andersonand NFAT4 (NFATx or NFATc3) (McCaffrey et al., 1993;
et al., 1995; Wang et al., 1995; Poetschke et al., 1996).Northrop et al., 1994; Hoey et al., 1995; Masuda et al.,
Additional evidence for distinct functions of NFAT pro-1995). Each of these NFAT proteins contains a series
teins comes from the analysis of NFATp- and NFATc-of serine/proline-rich repeats at the N terminus and a
deficient mice. NFATp-deficient mice have lymphoid hy-downstream Rel homology domain that shares approxi-
perplasia with hyperproliferation and elevated levels ofmately 20% homology to the DNA-binding domain of
IL-4 and IgE, while NFATc deficiency causes cardiacRel and the other NF-kB family members. The RHD is
valvular defects and defects in IL-4-driven responsesessential for DNA binding and dimerization with basic
(Hodge et al., 1996b; Xanthoudakis et al., 1996; Rangerregion/leucine zipper proteins such as the AP-1 family
et al., 1998a, 1998b). Thymic development, however, ismembers Jun and Fos (Boise et al., 1993; Jain et al.,
largely unperturbed in the absence of NFATp or NFATc.1992, 1993; Rooney et al., 1995a, 1995b).
To elucidate the function of NFAT4 in vivo, we haveIn resting T lymphocytes, NFAT proteins are present
generated NFAT4-deficient mice by targeted gene dis-
ruption. Here we report that these mice have a defect
in the generation of thymocytes characterized by in-§To whom correspondence should be addressed (e-mail: lglimche
creased apoptosis of DP thymocytes with a concomitant@hsph.harvard.edu).
‖ These authors contributed equally. decrease in mature SP thymocytes and peripheral T
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fertile and appeared healthy until at least 14 months
of age, with the exception of spontaneous periorbital
swelling in some animals. There were no other gross
pathologic or histologic abnormalities noted.
Diminished Numbers of CD4 and CD8 Cells in Thymus
and Spleen of NFAT4-Deficient Mice
Thymocytes, lymph node (LN), and spleen cell popula-
tions were isolated from control NFAT41/1 and mutant
NFAT42/2 mice and analyzed by double- and triple-color
immunofluorescence (Figure 2). A substantial decrease
(40%±60%) of mature CD41CD82 and CD81CD42 thy-
mocytes was found in all 2/2 mice examined (Figure
2A). This represented a decrease in the absolute num-
bers of SP thymocytes, since the total number of thymo-
cytes did not vary significantly between control and 2/2Figure 1. Targeted Disruption of the NFAT4 Gene
littermates. The number of DP thymocytes was normal.(A) Schematic representation of the NFAT4 targeting construct. The
Similar to thymus, a decrease in both CD4 and CD8 SPintron±exon structure of the 39 terminus of genomic DNA encoding
a portion of the NFAT4 Rel similarity domain (RHD) isolated from a T cells was observed in spleen (Figure 2B).
129/SvJ genomic library (top). Replacement construct containing To examine the defect in thymocyte development in
the HSV-tk and neomycin resistance (neor) genes both under the more detail, triple-color immunofluorescence with MAbs
control of the mouse phosphoglycerate kinase (PGK) promoter indi-
to CD4, CD8, and TcRb was performed. This allowedcating the replacement of the RHD (amino acids 535±592) with neo
us to determine levels of TcR on each thymocyte subset.(middle). The probes and restriction sites used for diagnostic South-
During positive selection, a small fraction of DP thymo-ern blotting are indicated.
(B) Southern blot analysis of ES cells that have undergone targeted cytes differentiates to SP cells, a step that is preceded
replacement at the NFAT4 locus, and the offspring of intercrossed by up-regulation of surface TcR. DP cells also up-regu-
heterozygous (1/2) mice. The Southern blot was probed with the late levels of two surface antigens, CD5 and CD69, as
39 probe that detects the 8.8 kb wt allele and the 6.3 kb targeted
they undergo positive selection. No abnormality in TcRallele.
levels was found on SP and transitional NFAT42/2(C) Western blot analysis with an NFAT4-specific polyclonal antise-
CD41CD8lo or CD4loCD81 thymocytes (data not shown).rum. Extracts from thymus of wt, 1/2, and 2/2 mice. The positions
of the molecular mass markers (in kilodaltons) are indicated. Similar to TcR expression, NFAT42/2 transitional cells
had no defect in CD5 or CD69 expression, although the
percentage of CD51 and CD691 cells was decreased
cells. This is accompanied by hyperactivation of periph- consistent with the absolute decrease in SP cells (Figure
eral T cells. An impairment in the production of Bcl-2 2C). The expression of other developmentally regulated
mRNA and protein is also present. antigens such as HSA and class I MHC were also normal
in NFAT42/2 thymus and spleen as was the pattern of
Results TcR Vb and Va gene usage as determined by flow cyto-
metric analysis with a panel of anti-TcR MAbs (data not
Generation of NFAT4-Deficient Mice shown). These data indicate a defect, but not a complete
To generate mice deficient for NFAT4, a targeting con- block, in the generation of both CD4 and CD8 SP T cells
struct containing the neomycin drug resistance (neo) in the absence of NFAT4.
gene was used to replace a region of the NFAT4 gene
encoding the DNA-binding domain (amino acids 535±592)
(Figure 1A) and embryonic stem (ES) cells containing NFAT4, Unlike NFATc and NFATp, Is Expressed
at Highest Levels in DP Thymocytesa disrupted NFAT4 allele identified. Germline chimeras
generated from one ES cell produced heterozygous In the adult animal, NFAT4 transcripts are found at high-
est levels in the thymus. Although transcripts encoding(1/2) mice that were then intercrossed to produce mice
homozygous (2/2) for the disrupted allele (Figure 1B). for NFATp and NFATc are also present in thymus (albeit
at lower levels than in the periphery), these latter NFATWestern blot analysis of (2/2) thymus extracts using
a polyclonal antisera specific for NFAT4 revealed an proteins cannot fully compensate for the absence of
NFAT4 as demonstrated above. The defects observedabsence of any immunoreactive polypeptides (Figure
1C), thus this mutation is a null allele. NFAT42/2 mice above suggested that NFAT4 might be especially impor-
tant to mediate the transition from a DP to SP thymocyte.were not born at the expected Mendelian ratio. Of 500
mice screened from 1/2 matings, there were 147 (29%) To compare levels of expression of the NFAT family
members in thymocyte subsets, wild-type (wt) thymo-1/1, 291 (58%) 1/2, and 62 (12%) 2/2 homozygous
offspring, yielding a ratio of approximately 12% rather cytes were isolated and purified by antibody depletion
and cell sorting into double-negative (DN), DP, and SPthan the expected 25%. The cause of intrauterine death
is not clear, since visual inspection of embryos did not subpopulations. RNA prepared from these populations
was then subjected to Northern analysis using probesreveal any gross abnormalities except that the 2/2 em-
bryos tended to be smaller. The lifespan of surviving from the NFAT4, NFATp, and NFATc genes. As shown
in Figure 3, the relative levels of expression of these2/2 mice was, however, normal. NFAT42/2 mice were
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Figure 3. Northern Blot Analysis of Thymocyte Development in Wt
and NFAT42/2 Mice
Northern blot analysis of NFAT family member expression in thymo-
cyte subsets with schematic representation. Levels of transcripts
were quantitated by densitometry, the number of 1.0 was assigned
arbitrarily to the sample with the highest level, and the other samples
were expressed relative to it.
Arai and colleagues (Amasaki et al., 1998). These pat-
terns of expression are consistent with the defect in
generation of SP thymocytes observed in NFAT42/2
mice and with the abnormalities observed in peripheralFigure 2. Flow Cytometric Analysis of Thymocyte and Peripheral
Lymphoid Development in NFAT42/2 Mice lymphoid cells in NFATp2/2 mice.
Lymphocytes from thymus (A and C) and spleen (B) of wt and
NFAT42/2 mice were stained with the TC-, PE-, or FITC-conjugated NFAT4-Deficient TcR Transgenic Mice Have
MAbs as indicated. Results from thymus and spleen are representa- a Defect in T Cell Development
tive of at least 20 mice in each group.
The decrease in CD4 and CD8 SP cells observed above(A) Thymocytes were triple-stained with anti-CD4-TC, anti-CD8-PE,
in thymus, together with the preferential expression ofand anti-b TcR-FITC. Histograms show ab TcR expression on total
NFAT4 in DP thymocytes, indicated impairment in thethymocytes. The histogram markers denote the mature TcR med/
hi subset. transition from the DP to SP stage. This could be sec-
(B) Erythrocyte-depleted spleen cells were triple stained with anti- ondary to impaired processes of positive selection or
CD4-TC, anti-CD8-PE, and anti-b TcR-FITC. For two-color plots, to increased cell death. Mice expressing specific trans-
the percentage of cells in each quadrant is listed. Histograms show
genic TcRs have provided valuable insight into mecha-the levels of ab TcR expression on total splenocytes.
nisms of positive and negative selection. To determine(C) Thymocytes were stained with anti-b TcR-PE and anti-CD69-
whether NFAT4 plays a role in the selection of T cellsFITC or with anti-b TcR-PE and anti-CD5-FITC. The numbers indi-
cate positively selected cells expressing high levels of TcR, CD69, having a single specificity, we introduced a TcR MHC
and CD5. class II±restricted transgene onto the NFAT4-deficient
background. The TcR transgenic line DO11.10 isspecific
for ovalbumin in the context of I-Ad or I-Ab (Murphy et
al., 1989). Positive selection of DO11.10 T cells on anthree NFAT family members during thymocyte develop-
ment is very different. NFAT4 is expressed at highest I-Ad background results in the appearance of mature
T cells that are virtually all CD41 and express high lev-levels in DP thymocytes, while NFATc is preferentially
expressed in DN thymocytes and NFATp in SP thymo- els of transgenic TcR a and b polypeptides (Murphy et
al., 1989). Analysis of the double-transgenic DO11.10cytes. Similar results have recently been published by
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transgenic but not nontransgenic NFAT42/2 thymi. We
therefore performed experiments to determine whether
DP NFAT42/2 thymocytes are more sensitive to apopto-
sis induced by TcR engagement using an in vitro system
of negative selection. Negative selection as defined by
apoptosis can be reproduced in vitro by culturing thymo-
cytes with anti-TcR MAbs that produce cross-linking or
by treatment with PMA and ionomycin (Kizaki et al.,
1989). DP thymocytes purified from NFAT42/2, NFAT42/2
DO11.10 TcR transgenic and control thymi were there-
fore tested for their sensitivity to apoptosis mediated
by TcR cross-linking or by PMA/ionomycin treatment.
As shown in Figure 5A, NFAT42/2 thymocytes were sig-
nificantly more sensitive to anti-TcR induced apoptosis
than control thymocytes. NFAT42/2 thymocytes also dis-
played increased apoptosis in response to PMA and
ionomycin treatment (data not shown). This result is
intriguing in light of the recent observation that TcR
cross-linking without costimulation could induce apo-
ptosis in the presence of CsA (Figure 5A; Poetschke et
al., 1996). The increase in apoptosis was even more
pronounced in DO11.10 TcR transgenic NFAT42/2 than
in NFAT42/2 nontransgenic DP thymocytes (Figure 5B).
We conclude that NFAT4 is important in protecting DP
thymocytes from apoptosis.
Although diminished in absolute number, an increased
percentage of CD4 and CD8 NFAT42/2 cells displayed
Figure 4. Decreased DP Thymocytes but Normal Positive Selection the CD44hi (data not shown) and MEL14 (CD62L)lo pheno-
in NFAT42/2 DO11.10 TcR Transgenic Mice type characteristic of memory/activated cells when
Flow cytometric analysis of thymocyte (A) and peripheral lymphoid compared to wt cells (Figure 5C). The presence of in-
(B) development in NFAT42/2 DO11.10 TcR transgenic mice. Two-
creased activation coupled with a decrease in numberscolor lots of CD4 versus CD8 staining are presented for each group.
of mature T cells suggested that peripheral cells might
also be experiencing increased rates of activation-
NFAT42/2 mice revealed that the thymus was approxi- induced cell death. Consistent with this idea, we ob-
mately 3-fold reduced in size when compared to DO11.10 served substantially increased levels of transcripts en-
NFAT41/1 littermates. There was a dramatic reduction in coding for FasL in NFAT42/2 spleen compared to wt
the proportion and absolute numbers of DP thymocytes, spleen (Figure 5D). Nevertheless, the proliferation (data
with a concomitant increase in proportion of DN thymo- not shown) and cytokine secretion of NFAT42/2 spleno-
cytes (Figure 4A). This data is reminiscent of previous cytes in response to plate-bound anti-CD3 antibody was
observations in TcR transgenic models that display normal (Figure 6). Thus, levels of IL-2, IL-4, and IFNg
small thymi and an increase in the DN thymocyte popula- did not differ significantly from control splenocytes (Fig-
tion secondary to increased thymic deletion. It is also ure 6), nor were differences in serum IgM, IgG, or IgE
possible that the accumulation of DN cells in the ab- levels detected (data not shown).
sence of NFAT4 is due to a block in the progression
from the DN to the DP stage. However, this is a less Impaired Expression of Bcl-2 in the
likely explanation given the normal DN to DP transition Absence of NFAT4
in NFAT42/2, nontransgenic thymi. Only a slight de- A number of proteins that regulate apoptosis in lympho-
crease in CD41 KJ126 clonotype-positive T cells was cytes have been identified (Thompson, 1995). bcl-2 is
present in the thymus; however, there was a reduction one member of a family of genes that act as death
in the number of CD41 T cells in spleen, suggesting repressors, and it has been shown to protect developing
impaired survival in the periphery (Figure 4B). and mature T cells against a variety of apoptotic signals
such as cross-linking of surface receptors (Reed, 1997;
Increased Apoptosis of DP Thymocytes Jacobson, 1997). Interestingly, Bcl-2 is expressed at
and Increased Activation of Peripheral low levels in DP thymocytes and is up-regulated as DP
T Cells in the Absence of NFAT4 thymocytes transit to the SP stage (Gratiot-Deans et al.,
The decrease in the proportion of abTcR-high DP thy- 1994; Linette et al., 1994). We assessed intracellular
mocytes observed in mice lacking NFAT4 could be sec- levels of Bcl-2 protein in thymocyte subsets from control
ondary to impaired cell division or to increased cell and mutant mice by three-color flow cytometry using a
death, the latter most likely due to increased apoptosis Bcl-2-specific antibody together with anti-CD4 and -CD8
at the time of TcR up-regulation. In TcR transgenic Abs. A marked reduction in levels of Bcl-2 was present
NFAT42/2 mice, a larger proportion of T cells have cou- in transitional CD4hiCD8lo and CD4 SP thymocytes from
pled surface TcR/CD3 complexes to the appropriate the NFAT42/2 as compared to control mice (Figure 7A).
signaling pathway prior to this stage, thus resulting in While Bcl-2 is expressed preferentially in SP thymo-
cytes, NFAT4, in contrast, is expressed at highest levelsthe dramatic decrease in DP thymocytes observed in
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Figure 5. Increased Sensitivity to Apoptosis and Hyperactivation of Spleen Cells in NFAT42/2 Mice
(A and B) Increased apoptosis induced by treatment of NFAT42/2 DP thymocytes with anti-TcR MAb. Purified populations of DP thymocytes
from NFAT42/2, NFAT42/2 DO11.10 TcR transgenic, or control littermates were cultured for 20 hr on anti-CD3 (5 mg/ml) coated plates in the
presence or absence of cyclosporin. Apoptosis was measured by TUNEL staining as described (Gavrieli et al., 1992; Gorczyca et al., 1992).
Results presented are representative of three separate experiments.
(C) Erythrocyte-depleted spleen cells were stained with anti-CD62L (MEL14)-FITC. Histograms show the levels of expression on CD4 and CD8
T cells.
(D) Northern analysis of FasL expression in wt and NFAT42/2 spleen.
in DP thymocytes, raising the possibility that it regulates fail to generate normal numbers of CD4 and CD8 SP
thymocytes and mature T cells. This defect is not duebcl-2 gene expression. Evidence to support this idea
was obtained from Northern blot analysis of Bcl-2 ex- to impaired positive selection as revealed by analysis
of NFAT42/2 DO11.10 TcR transgenic mice. Rather, thispression in thymocyte subsets of control and NFAT42/2
mice. Levels of Bcl-2 transcripts were markedly reduced defect in generation of SP cells in the thymus is charac-
terized by an increased sensitivity of NFAT4-deficientin SP thymocytes of mutant as compared to control
animals (Figure 7B). Taken together, these data suggest DP thymocytes to apoptosis, likely due to an altered
threshhold of signaling via the TcR. The increase in apo-that the increase in apoptosis observed in NFAT42/ thy-
mocytes may be partly secondary to a failure to up- ptosis is also accompanied by impaired induction of the
anti-apoptotic protein Bcl-2 in SP thymocytes, sug-regulate levels of the death repressor protein Bcl-2 as
DP thymocytes transit to the SP stage. gesting that NFAT4 plays an important role in the thymic
regulation of this key molecule.
It is generally accepted that the affinity of the TcRDiscussion
for its MHC/peptide ligand determines the fate of the
developing thymocyte. Weak interactions are thought toHere we show that the transcription factor NFAT4 is
highly expressed in DP thymocytes. Mice lacking NFAT4 favor positive selection, while higher affinity interactions
Figure 6. Cytokine Production by NFAT42/2
Mice
Cytokine production as measured by ELISA
of wt and NFAT42/2 splenocytes in response
to plate-bound anti-CD3. Production of IL-2
was quantitated at 24 hr; production of IL-4
and IFNg was quantitated at 48 hr.
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Figure 7. Impaired Up-Regulation of Bcl-2 in
DP Thymocytes of NFAT42/2 Mice
(A) Intracytoplasmic staining of thymocytes.
Permeabilized thymocytes were stained with
a MAb (3F11) specific for murine Bcl-2 fol-
lowed by goat anti-hamster IgG biotin and
FITC-streptavidin. Cells were counterstained
with anti-CD4-TC and anti-CD8-PE and ana-
lyzed as described in Experimental Proce-
dures. Histograms show levels of Bcl-2 ex-
pression gated on different subpopulations
of thymocytes.
(B) Northern blot analysis of Bcl-2 expression
in the DN, DP, and SP thymocyte subsets of
wt and NFAT42/2 mice. RNA was prepared
from thymocytes from wt and NFAT42/2 mice
purified as described above, and blots were
hybridized with a 700 bp Bcl-2 cDNA probe
(Veis et al., 1993b).
result in negative selection (Bevan, 1997). Differences (Fischer et al., 1998; Holsinger et al., 1998). Since the
nuclear translocation of NFAT4 is regulated by cal-between the signaling requirements for positive and
negative selection have been observed. p21 Ras and cineurin, it was tempting to speculate that NFAT4 was
involved in TcR signaling and CsA-sensitive events in DPthe MAP kinase MEK1, a downstream effector of p21
Ras, have been strongly implicated in processes of posi- thymocytes, the site at which NFAT4 is predominantly
expressed. Further, NFAT DNA-binding activity in thy-tive but not negative selection (Alberola-Ila et al., 1995,
1996; Turner and Cantrell, 1997). CsA and FK506, cal- mocytes is largely composed of NFAT4 (Amasaki et al.,
1998). Indeed, our data demonstrate that the generationcineurin inhibitors, inhibit positive selection but do not
impede negative selection. Further, mice lacking the of SP thymocytes is impaired (approximately 50% re-
duction in both percentage and absolute number) innucleotide exchange factor VAV that interacts with
ZAP70 also display a profound defect in the generation mice lacking NFAT4.
The absence of NFAT4 had a more profound effectof SP thymocytes (Turner et al., 1997), and these authors
have suggested that VAV may influence the efficiency on the development of T cells bearing a defined TcR
transgene than on the broad repertoire of T cells inof TcR-mediated selection by regulating intracellular
calcium fluxes in thymocytes. Overexpression of VAV transgene-negative mice lacking NFAT4. In mice ex-
pressing the class II±restricted DO11.10 TcR transgene,augments basal and TcR-stimulated NFAT-dependent
reporter gene expression in the Jurkat T cell lymphoma loss of NFAT4 resulted in a reduction in the size of the
thymus and a marked reduction in the DP thymocyte(Gulbins et al., 1993; Wu et al., 1995), and NFAT activity
cannot be induced in VAV2/2 T cells. This augmentation population, a reduction that was not observed in
NFAT42/2 transgene±negative thymus. The specific re-is blocked by CsA and FK506 and by overexpression of
a dominant negative form of Ras (Alberola-Ila et al., duction in the proportion of ab high DP thymocytes in
the latter coincides with the stage at which apoptosis1996). Blockade of the MAPK cascade by expression of
catalytically inactive MEK-1 inhibits NFAT-dependent occurs and suggested the possibility that DP NFAT42/2
thymocytes might be more sensitive to TcR-mediatedtranscription in T cell lines (Alberola-Ila et al., 1995,
1996), but surprisingly, the phoshphorylation and activ- death. In DO11.10 transgenic thymus, a larger percent-
age of T cells have already coupled TcR/CD3 complexesity of both MAPK and SAP/JNK proteins in response
to TcR signaling are unaffected in VAV2/2 thymocytes to the appropriate signaling molecules, resulting in a
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heightened sensitivity to apoptosis and the ensuing de- Further, NFAT4 may act to down-regulate the immune
response, since in its absence both CD4 and CD8 Tcrease in DP thymocytes. Our experiments indeed dem-
cells appear activated. The decrease in NFAT4 expres-onstrated that TcR engagement was able to induce apo-
sion after T cell activation (unpublished data) is consis-ptosis in a significant number of DP thymocytes from
tent with this idea. A similar hyperactivated phenotypeNFAT4-deficient but not from wt mice, and this in-
was observed in mice lacking the gc chain or Jak3 genescreased sensitivity was more apparent in DO11.10
(Leonard, 1996; Nakajima et al., 1997; Thomis and Berg,transgenic NFAT42/2 thymocytes. Overall, signal trans-
1997) and, interestingly, was attributed to a defect induction pathways emanating from the TcR converge
Bcl-2 expression (Kondo et al., 1997; Nakajima et al.,upon and regulate the transcription of NFAT-dependent
1997). It is likely that each NFAT family member regulatesgenes such as IL-2 and concurrently regulate thymic
distinct subsets of early response genes and that suchpositive and negative selection. Our findings suggest
regulation might depend in part upon the temporallythat NFAT4 may be the NFAT family member most im-
distinct patterns of NFAT induction during the courseportant in regulating the generation of CD4 and CD8 SP
of an immune response. Intercrosses and the produc-cells by controlling the intensity of the signal generated
tion of lymphoid chimeras between mice deficient inby binding of TcR to its selecting ligand. We would
each of the three NFAT family members should provepostulate that the threshhold at which T cells can be
informative in this regard.activated is lowered in the absence of NFAT4, resulting
NFAT4-deficient thymocytes display heightened sen-in a signal of higher intensity being delivered. Thus, the
sitivity to apoptosis mediated through theTcR. One pos-efficiency of positive selection is compromised because
sibility is that NFAT4 prevents apoptosis by controllingthe higher intensity signal causes thymocytes to die by
the expression of genes involved in cell survival. Onenegative selection. This higher intensity signal is re-
such anti-apoptotic protein is Bcl-2 (Vaux et al., 1988;flected in the hyperactivated state of NFAT42/2 periph-
Hockenbery et al., 1990, 1993; Strasser et al., 1991). Theeral T cells.
up-regulation of Bcl-2 from the DP to SP stage may beThree of the four members of the NFAT family, NFATp,
an important event in positive selection (Gratiot-Deans
NFATc, and NFAT4, are present in thymus and in periph-
et al., 1994; Strasser et al., 1994b) and is due, at least
eral lymphocytes. However, the pattern of expression
in part, to engagement of the IL-7 receptor (Akashi et
of each member differs during thymocyte development
al., 1997; Kondo et al., 1997; Maraskovsky et al., 1997).
(Figure 3; Amasaki et al., 1998) and in response to T Bcl-2-deficient mice undergo massive thymic apoptosis
cell activation (unpublished data). The phenotype of the shortly after birth, making itdifficult to assess thymocyte
NFAT4-deficient mice presented here demonstrates development (Veis et al., 1993b). However, overexpres-
that this member of theNFAT family is particularly impor- sion of Bcl-2 has been shown to rescue positive selec-
tant in thymic functions. This is consistent with the nor- tion in MHC-deficient mice (Linette et al., 1994), although
mal T cell development observed in mice whose thymi this has been controversial (Cory, 1995; Strasser et al.,
lack either NFATp or NFATc, the other two members of 1994a), and rescues the defective positive selection ob-
this family that are expressed in lymphocytes. However, served in IL-7 receptor mutant mice (Akashi et al., 1997).
only a partial inhibition of T cellproduction was observed Further, the relative levels of Bcl-2 and the related pro-
in the absence of NFAT4. Thus, NFATp or NFATc may tein Bax have a considerable effect on thymocyte devel-
partially compensate for the lack of NFAT4. An alterna- opment. Positive selection is impaired in Bax alpha over-
tive explanation for the partial defect observed is that expressor transgenic mice due to accelerated apoptosis
non±NFAT family transcription factors can compensate (Brady et al., 1996). A single copy of bax promoted apo-
for the absence of NFAT4. One candidate is the early ptosis in the absence of Bcl-2; in contrast, Bcl-2 overex-
growth response gene (Egr), a zinc finger transcription pression repressed apoptosis in the absence of Bax
factor whose expression correlates with positive selec- (Knudson and Korsmeyer, 1997; Brady et al., 1996). The
tion (Shao et al., 1997). Interestingly, CsA has been impaired induction of Bcl-2 mRNA and protein in both
shown to block the expression of certain members of transitional and SP thymocytes in NFAT4-deficient mice
the Egr family. Further, Egr expression is itself induced may provide an explanation for the increased apoptosis
via activation of the Ras signal transduction pathway. observed. Thus, changes in the absolute levels of Bcl-2
Other proteins such as Notch and the transcription fac- or in the relative levels of Bcl-2 and Bax in NFAT4-
tor IRF-1 appear to be required for lineage commitment deficient thymocytes secondary to the impairment of
Bcl-2 expression might alter sensitivity to apoptosis.and selection of CD81 but not CD41 thymocytes (Pen-
Initial examination of the bcl-2 promoter reveals sites forninger et al., 1997; von Boehmer, 1997; Washburn et al.,
the Ets family of transcription factors and one canonical1997).
NFAT site at 21176 to 21183 bp (Negrini et al., 1987).In contrast to the impaired T cell development ob-
However, sequence information for only 1.7 kb of theserved in NFAT4-deficient mice, cytokine production
bcl-2 promoter is available, and there may well be addi-was normal. This result is not surprising given the 10-
tional NFAT sites elsewhere in the gene. When this pro-fold lower affinity that NFAT4 displays for the NFAT
moter has been better characterized, it will be of interestsite in the IL-4 promoter and its failure to participate in
to determine if NFAT4 does in fact directly control thecomplex formation at the IL-2 NFAT site when compared
transcription of the bcl-2 gene.to NFATp or NFATc (Timmerman et al., 1997). However,
in other studies, no difference was observed in the DNA-
Experimental Proceduresbinding specificity of NFAT4 compared to other NFAT
family members, raising the possibility that these latter Disruption of the NFAT4 Gene
proteins compensate for the absence of NFAT4 in regu- A cDNA fragment encoding the Rel homology domain of the NFAT4
gene was used as a probe to isolate clones from a 129/SvJ genomiclating cytokine gene transcription (Hoey et al., 1995).
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library. A 1.2 kb fragment from the NFAT4 genomic clone was re- Measurement of Cytokine Levels by ELISA
Spleen or LN cells (5 3 105) from 1/1 or 2/2 NFAT4 mice wereplaced with a thymidine kinase promoter-neo-poly(A) cassette from
pMC1neopoly(A) (Stratagene). The replacement cassette was pre- incubated per well of a 96-well plate previously coated with anti-
CD3e (10 mg/ml) for 48 hr. Supernatants from the cultures abovepared by transferring a HindIII/BamH1 fragment containing approxi-
mately 1.6 kb of 59 NFAT4 sequence, the neo cassette, and 6 kb of were assayed for levels of IL-2, IL-4, and IFNg by ELISA (Phar-
mingen), as previously described (Hodge et al., 1996b).39 NFAT4 sequence to a plasmid encoding the thymidine kinase drug
resistance gene. D3 ES cell clones transfected with the targeting
construct were selected for drug resistance in 180 mg/ml G418 and Acknowledgments
2 mM gancyclovir. Homologous recombinants were screened for by
digesting genomic DNA from drug-resistant clones. Of several We thank Dr. Terri Laufer for a careful review of the manuscript,
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